Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-25-086561
Filing Date
2025-09-03
Accepted
2025-09-02 20:20:23
Documents
17

Document Format Files

Seq Description Document Type Size
1 S-3 tm2524971-1_s3.htm S-3 307123
2 EXHIBIT 5.1 tm2524971d2_ex5-1.htm EX-5.1 12886
3 EXHIBIT 23.2 tm2524971d2_ex23-2.htm EX-23.2 2441
4 EX-FILING FEES tm2524971d1_ex-filingfees.htm   iXBRL EX-FILING FEES 25864
5 GRAPHIC tm2524971d2_ex5-1img001.jpg GRAPHIC 3532
6 GRAPHIC tm2524971d2_ex5-1img002.jpg GRAPHIC 2369
7 GRAPHIC lg_immuneering-4clr.jpg GRAPHIC 10129
  Complete submission text file 0001104659-25-086561.txt   494702

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2524971d1_ex-filingfees_htm.xml XML 5237
Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Filer) CIK: 0001790340 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-289997 | Film No.: 251287436
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)